Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Cytokeratin 19 anticorps

KRT19 Reactivité: Humain, Souris FACS, IF, IHC (p) Hôte: Souris Monoclonal KRT19-799-KRT19-800 unconjugated
N° du produit ABIN3025848
  • Antigène Voir toutes Cytokeratin 19 (KRT19) Anticorps
    Cytokeratin 19 (KRT19) (Keratin 19 (KRT19))
    Reactivité
    • 263
    • 89
    • 72
    • 8
    • 7
    • 7
    • 5
    • 5
    • 4
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    Humain, Souris
    Hôte
    • 138
    • 134
    • 3
    • 2
    • 1
    Souris
    Clonalité
    • 146
    • 132
    Monoclonal
    Conjugué
    • 124
    • 33
    • 20
    • 13
    • 7
    • 6
    • 6
    • 5
    • 5
    • 5
    • 5
    • 5
    • 4
    • 4
    • 4
    • 4
    • 4
    • 4
    • 3
    • 3
    • 3
    • 3
    • 3
    • 2
    • 2
    • 1
    • 1
    Cet anticorp Cytokeratin 19 est non-conjugé
    Application
    • 192
    • 96
    • 87
    • 81
    • 68
    • 47
    • 40
    • 39
    • 33
    • 31
    • 24
    • 23
    • 7
    • 6
    • 6
    • 5
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Flow Cytometry (FACS), Immunofluorescence (IF), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
    Purification
    Protein G affinity chromatography
    Immunogène
    Recombinant full-length human KRT19 protein was used as the immunogen for the Cytokeratin 19 antibody cocktail.
    Clone
    KRT19-799-KRT19-800
    Isotype
    IgG1, IgG2a kappa
    Top Product
    Discover our top product KRT19 Anticorps primaire
  • Indications d'application
    Optimal dilution of the Cytokeratin 19 antibody cocktail should be determined by the researcher.

    1. Staining of formalin-fixed tissues requires boiling tissue sections in 10  mM Citrate buffer,  pH 6.0, for 10-20 min followed by cooling at RT for 20 min
    2. The prediluted format is supplied in a dropper bottle and is optimized for use in IHC. After epitope retrieval step (if required), drip mAb solution onto the tissue section and incubate at RT for 30 min.\. Flow Cytometry: 0.5-1 μg/million cells in 0.1ml,Immunofluorescence: 1-2 μg/mL,Immunohistochemistry (FFPE): 0.5-1 μg/mL for 30 min at RT (1),Prediluted format : incubate for 30 min at RT (2)

    Restrictions
    For Research Use only
  • Concentration
    0.2 mg/mL
    Buffer
    0.2 mg/mL in 1X PBS with 0.1 mg/mL BSA (US sourced) and 0.05 % sodium azide
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    4 °C,-20 °C
    Stockage commentaire
    Store the Cytokeratin 19 antibody cocktail at 2-8°C (with azide) or aliquot and store at -20°C or colder (without azide).
  • Antigène
    Cytokeratin 19 (KRT19) (Keratin 19 (KRT19))
    Autre désignation
    Cytokeratin 19 (KRT19 Produits)
    Synonymes
    anticorps CK19, anticorps K19, anticorps K1CS, anticorps AI663979, anticorps EndoC, anticorps Krt-1.19, anticorps Krt1-19, anticorps Ka19, anticorps k19, anticorps ck19, anticorps k1cs, anticorps krt9, anticorps krt15, anticorps MGC76282, anticorps GK-19, anticorps MGC83069, anticorps KRT19, anticorps keratin 19, anticorps keratin 19 L homeolog, anticorps keratin, type I cytoskeletal 19, anticorps KRT19, anticorps Krt19, anticorps krt19, anticorps krt19.L, anticorps LOC100344434, anticorps LOC101117946
    Sujet
    Recognizes a protein of 40  kDa, identified as cytokeratin-19 (CK19), which is expressed in sweat gland, mammary gland ductal and secretory cells, bile ducts, gastrointestinal tract, bladder urothelium, oral epithelia, esophagus, and ectocervical epithelium. Anti-CK19 reacts with a wide variety of epithelial malignancies including adenocarcinomas of the colon, stomach, pancreas, biliary tract, liver, and breast. Perhaps the most useful application is the identification of thyroid carcinoma of the papillary type, although 50 % -60 % of follicular carcinomas are also labeled. Anti-CK19 is a useful marker for detection of tumor cells in lymph nodes, peripheral blood, bone marrow and breast cancer.
Vous êtes ici:
Support technique